Table 2.
Details and nature of p53 mutations in colorectal cancer patients from Kashmir valley
Patient ID | Age/sexa | Rural/urbanb | Duke's stagec | Smoking statusd | Gradee | Sitef | Typeg | Natureh | Exon | Codon number | Base changei | Aminoacid change | Effectj |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1X | 55/M | R | A | NSk | III | C | AC | HNPCC | 5 | 175 | CGC > CAC | Arg > His | MS |
2X | 72/M | R | D | NSk | III | R | MAC | S | 5 | 154 | GGC > GGT | Gly > Gly | MSS |
7 | 248 | CGG > TGG | Arg > Trp | MS | |||||||||
5X | 68/F | U | D | NSk | II | R | AC | S | 7 | 248 | CGG > TGG | Arg > Trp | MS |
8 | 265 | CTG > CCG | Leu > Pro | MS | |||||||||
8X | 51/M | U | B | NSk | I | C | AC | S | 6 | 221 | GAG > GAC | Glu > Asp | MS |
11X | 45/M | R | D | Sk | III | R | AC | S | 6 | 196 | CGA > CAA | Arg > Stop | TP |
14X | 82/F | U | C | Sk | II | R | AC | S | 6 | 222 | CCG > CCC | Pro > Pro | MSS |
8 | 264 | CTA > TCTA | Leu >>>> | FS | |||||||||
16X | 62/F | U | C | Sk | II | C | AC | S | 5 | 181 | CGC > TGC | Arg > Cys | MS |
6 | 209 | AGA > AAA | Arg > Lys | MS | |||||||||
19X | 67/M | R | D | NSk | III | R | AC | S | 8 | 282 | CGG > TGG | Arg > Trp | MS |
21X | 66/F | R | C | NSk | II | R | AC | S | 7 | 245 | GGC > AGC | Gly > Ser | MS |
22X | 77/M | U | C | Sk | I | R | AC | S | 6 | 202 | CGT > CTT | Arg > Leu | MS |
8 | 272 | GTG > ATG | Val > Met | MS | |||||||||
27X | 69/M | R | C | Sk | III | R | AC | S | 5 | 177 | CCC > CTC | Pro > Leu | MS |
8 | 304 | ACT > TACT | Thr>>>> | FS | |||||||||
28X | 42/M | U | C | Sk | II | R | MAC | S | 8 | 261 | AGT > AGG | Ser > Arg | MS |
31X | 64/M | R | C | Sk | II | C | AC | FAP | 6 | 224 | GAG > GAA | Glu > Glu | MSS |
8 | 297 | CAC > CTAC | His >>>> | FS | |||||||||
33X | 71/M | R | D | Sk | III | R | AC | S | 5 | 171 | GAG > CAG | Glu > Gln | MS |
5 | 174 | AGG > AGAG | Arg >>>> | FS | |||||||||
36X | 68/M | R | C | Sk | II | R | AC | S | 6 | 192 | CAG > TAG | Arg > Stop | TP |
37X | 60/F | U | C | NSk | III | R | AC | S | 5 | 155 | ACC > GCC | Thr > Ala | MS |
39X | 75/M | R | D | Sk | III | R | AC | S | 7 | 248 | CGG > CAG | Arg > Gln | MS |
41X | 72/M | R | C | Sk | II | R | AC | S | 5 | 176 | TGC > TGG | Cys > Trp | MS |
42X | 70/F | R | C | Sk | III | R | AC | S | 5 | 166 | TCA > ATCA | Ser>>>> | FS |
5 | 175 | CGC > CAC | Arg > His | MS |
Age/Sex: M = Male, F = Female;
Rural/Urban: R = Rural, U = Urban;
Duke's stage: A - Tumor confined to the intestinal wall; B - Tumor invading through the intestinal wall; C - With lymph node(s) involvement; D - With distant metastasis;
Smoking status: Sk: Smokers; NSk: Non smokers;
Grade stage: Stage I: T1/T2, N0, M0; Stage II: T3/T4, N0, M0; Stage III: Any, N1/N2, M0; Stage IV: AnyT, AnyN, M1;
Site of tumor: C = Colon, R = Rectum;
Tumor type: AC = Adenocarcinoma, MAC = Mucoid adenocarcinoma;
Nature of tumor: S: Sporadic; FAP: Familial adenomatous polyposis; HNPCC: Hereditary nonpolyposis colorectal cancer;
Base change: Mutated or inserted nucleotide underlined;
Effect: MS = Missense; FS = frameshift; MSS = Missense silent; TP = Truncated protein